Sphingosine 1-phosphate, a key mediator of the cytokine network: Juxtacrine signaling

Cytokine and Growth Factor Reviews

Volumn 22, Issue 1, 2011, Pages 45-53

  Xia, Pu ^a   Wadham, Carol ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cell signaling; Cytokines; Inflammation; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

ACTIVATED PROTEIN C; FINGOLIMOD; GAMMA INTERFERON; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; RANTES; SPHINGOSINE 1 PHOSPHATE; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; APOPTOSIS; ASTHMA; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CELL MEMBRANE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; DRUG EFFICACY; ENTERITIS; GENE ACTIVATION; HUMAN; HYDROPHOBICITY; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; LUNG INJURY; MACROPHAGE; MONOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; CELL COMMUNICATION; CYTOKINES; GENE REGULATORY NETWORKS; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 79952250059     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2010.09.004     Document Type: Short Survey

References (127)

1. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4:397-407.
2. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008, 9:139-150.
3. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 2010, 10:489-503.
4. Rosen H., Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005, 5:560-570.
5. Rivera J., Proia R.L., Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008, 8:753-763.
6. Xia P. Letter by Xia regarding article " High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor" Circulation 2007, 115:e393. [author reply e394].
7. Merrill A.H., Caligan T.B., Wang E., Peters K., Ou J. Analysis of sphingoid bases and sphingoid base 1-phosphates by high-performance liquid chromatography. Methods Enzymol 2000, 312:3-9.
8. Hla T., Lee M.J., Ancellin N., Paik J.H., Kluk M.J. Lysophospholipids - receptor revelations. Science 2001, 294:1875-1878.
9. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
10. Bezbradica J.S., Medzhitov R. Integration of cytokine and heterologous receptor signaling pathways. Nat Immunol 2009, 10:333-339.
11. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005, 25:11113-11121.
12. Spiegel S., Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 2007, 282:2125-2129.
13. Hait N.C., Allegood J., Maceyka M., Strub G.M., Harikumar K.B., Singh S.K., et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009, 325:1254-1257.
14. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 1991, 114:155-167.
15. Olivera A., Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993, 365:557-560.
16. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
17. Saba J.D., Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 2004, 94:724-734.
18. Xia P., Gamble J.R., Rye K.A., Wang L., Hii C.S., Cockerill P., et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci U S A 1998, 95:14196-14201.
19. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
20. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
21. Yadav M., Clark L., Schorey J.S. Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase. J Immunol 2006, 176:5494-5503.
22. Zhi L., Leung B.P., Melendez A.J. Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes. J Cell Physiol 2006, 208:109-115.
23. MacKinnon A.C., Buckley A., Chilvers E.R., Rossi A.G., Haslett C., Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 2002, 169:6394-6400.
24. Xia P., Wang L., Gamble J.R., Vadas M.A. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 1999, 274:34499-34505.
25. Xia P., Wang L., Moretti P.A., Albanese N., Chai F., Pitson S.M., et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem 2002, 277:7996-8003.
26. Alvarez S.E., Harikumar K.B., Hait N.C., Allegood J., Strub G.M., Kim E.Y., et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010, 465:1084-1088.
27. Pitson S.M., Moretti P.A., Zebol J.R., Lynn H.E., Xia P., Vadas M.A., et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 2003, 22:5491-5500.
28. Xia P., Vadas M.A., Rye K.A., Barter P.J., Gamble J.R. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 1999, 274:33143-33147.
29. Pettus B.J., Bielawski J., Porcelli A.M., Reames D.L., Johnson K.R., Morrow J., et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J 2003, 17:1411-1421.
30. Billich A., Bornancin F., Mechtcheriakova D., Natt F., Huesken D., Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell Signal 2005, 17:1203-1217.
31. Chandru H., Boggaram V. The role of sphingosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cells. Gene 2007, 391:150-160.
32. Melendez A.J. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim Biophys Acta 2008, 1784:66-75.
33. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
34. Rahimi R.A., Leof E.B. TGF-beta signaling: a tale of two responses. J Cell Biochem 2007, 102:593-608.
35. Li M.O., Flavell R.A. TGF-beta: a master of all T cell trades. Cell 2008, 134:392-404.
36. Gamble J.R., Vadas M.A. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. Science 1988, 242:97-99.
37. Gamble J.R., Xia P., Vadas M. The transforming growth factor family and the endothelium. TGF-beta and related cytokines in inflammation 2001, 41-64. Verlag Basel, Switzerland, Birkhauser. S.N. Breit, S.M. Wahl (Eds.).
38. Yamanaka M., Shegogue D., Pei H., Bu S., Bielawska A., Bielawski J., et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. J Biol Chem 2004, 279:53994-54001.
39. Kono Y., Nishiuma T., Nishimura Y., Kotani Y., Okada T., Nakamura S., et al. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol 2007, 37:395-404.
40. Miller A.V., Alvarez S.E., Spiegel S., Lebman D.A. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol 2008, 28:4142-4151.
41. Donati C., Cencetti F., De Palma C., Rapizzi E., Brunelli S., Cossu G., et al. TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. Cell Signal 2009, 21:228-236.
42. Cencetti F., Bernacchioni C., Nincheri P., Donati C., Bruni P. Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol Biol Cell 2010, 21:1111-1124.
43. Xin C., Ren S., Kleuser B., Shabahang S., Eberhardt W., Radeke H., et al. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J Biol Chem 2004, 279:35255-35262.
44. Yatomi Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995, 86:193-202.
45. Igarashi Y. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways. J Biochem 1997, 122:1080-1087.
46. Hanel P., Andreani P., Graler M.H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007, 21:1202-1209.
47. Venkataraman K., Lee Y.M., Michaud J., Thangada S., Ai Y., Bonkovsky H.L., et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008, 102:669-676.
48. Murata N., Sato K., Kon J., Tomura H., Yanagita M., Kuwabara A., et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 2000, 352 Pt(3):809-815.
49. Takabe K., Paugh S.W., Milstien S., Spiegel S. " Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008, 60:181-195.
50. Hla T., Venkataraman K., Michaud J. The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta 2008, 1781:477-482.
51. Wang L., Holmes A., Wadham C., Gamble J.R., Vadas M.A., Xia P. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 2005, 97:891-899.
52. Pham T.H., Baluk P., Xu Y., Grigorova I., Bankovich A.J., Pappu R., et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 2010, 207:17-27.
53. Niessen F., Schaffner F., Furlan-Freguia C., Pawlinski R., Bhattacharjee G., Chun J., et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008, 452:654-658.
54. Patel K.D., Lorant E., Jones D.A., Prescott M., McIntyre T.M., Zimmerman G.A. Juxtacrine interactions of endothelial cells with leukocytes: tethering and signaling molecules. Behring Inst Mitt 1993, 144-164.
55. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M., et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999, 99:301-312.
56. Gratzinger D., Canosa S., Engelhardt B., Madri J.A. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J 2003, 17:1458-1469.
57. Fukuda Y., Aoyama Y., Wada A., Igarashi Y. Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonist-induced phosphorylation. Biochim Biophys Acta 2004, 1636:12-21.
58. Limaye V., Li X., Hahn C., Xia P., Vadas M.A., Gamble J.R. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 2005, 105:3169-3177.
59. Lee J.F., Zeng Q., Ozaki H., Wang L., Hand A.R., Hla T., et al. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem 2006, 281:29190-29200.
60. Halin C., Scimone M.L., Bonasio R., Gauguet J.M., Mempel T.R., Quackenbush E., et al. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 2005, 106:1314-1322.
61. Aoki S., Yatomi Y., Shimosawa T., Yamashita H., Kitayama J., Tsuno N.H., et al. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3). J Thromb Haemost 2007, 5:1292-1301.
62. Cao C., Gao Y., Li Y., Antalis T.M., Castellino F.J., Zhang L. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest 2010, 120:1971-1980.
63. Ledgerwood L.G., Lal G., Zhang N., Garin A., Esses S.J., Ginhoux F., et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 2008, 9:42-53.
64. Pitson S.M., Xia P., Leclercq T.M., Moretti P.A., Zebol J.R., Lynn H.E., et al. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 2005, 201:49-54.
65. Sukocheva O., Wadham C., Holmes A., Albanese N., Verrier E., Feng F., et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 2006, 173:301-310.
66. Mitra P., Oskeritzian C.A., Payne S.G., Beaven M.A., Milstien S., Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 2006, 103:16394-16399.
67. Kobayashi N., Kobayashi N., Yamaguchi A., Nishi T. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 2009, 284:21192-21200.
68. Kawahara A., Nishi T., Hisano Y., Fukui H., Yamaguchi A., Mochizuki N. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 2009, 323:524-527.
69. Lee M.J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998, 279:1552-1555.
70. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000, 106:951-961.
71. Garcia J.G., Liu F., Verin A.D., Birukova A., Dechert M.A., Gerthoffer W.T., et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001, 108:689-701.
72. Tauseef M., Kini V., Knezevic N., Brannan M., Ramchandaran R., Fyrst H., et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 2008, 103:1164-1172.
73. Idzko M., Hammad H., van Nimwegen M., Kool M., Muller T., Soullie T., et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006, 116:2935-2944.
74. Czeloth N., Schippers A., Wagner N., Muller W., Kuster B., Bernhardt G., et al. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J Immunol 2007, 179:5855-5863.
75. Walzer T., Chiossone L., Chaix J., Calver A., Carozzo C., Garrigue-Antar L., et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007, 8:1337-1344.
76. Oskeritzian C.A., Price M.M., Hait N.C., Kapitonov D., Falanga Y.T., Morales J.K., et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med 2010, 207:465-474.
77. Michaud J., Im D.S., Hla T. Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. J Immunol 2010, 184:1475-1483.
78. Olivera A., Eisner C., Kitamura Y., Dillahunt S., Allende L., Tuymetova G., et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 2010, 120:1429-1440.
79. Mattie M., Brooker G., Spiegel S. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem 1994, 269:3181-3188.
80. Alvarez S.E., Milstien S., Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 2007, 18:300-307.
81. Snider A.J., Orr Gandy K.A., Obeid L.M. Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie 2010, 92:707-715.
82. Billich A., Urtz N., Reuschel R., Baumruker T. Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells. Int J Biochem Cell Biol 2009, 41:1547-1555.
83. Maines L.W., Fitzpatrick L.R., French K.J., Zhuang Y., Xia Z., Keller S.N., et al. Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci 2008, 53:997-1012.
84. Kawamori T., Kaneshiro T., Okumura M., Maalouf S., Uflacker A., Bielawski J., et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 2009, 23:405-414.
85. Alemany R., Meyer zu Heringdorf D., van Koppen C.J., Jakobs K.H. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J Biol Chem 1999, 274:3994-3999.
86. Niwa M., Kozawa O., Matsuno H., Kanamori Y., Hara A., Uematsu T. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sci 2000, 66:245-256.
87. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008, 102:950-958.
88. Camerer E., Regard J.B., Cornelissen I., Srinivasan Y., Duong D.N., Palmer D., et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 2009, 119:1871-1879.
89. Feistritzer C., Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 2005, 105:3178-3184.
90. Chen X.L., Grey J.Y., Thomas S., Qiu F.H., Medford R.M., Wasserman M.A., et al. Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. Am J Physiol Heart Circ Physiol 2004, 287:H1452-1458.
91. Huwiler A., Doll F., Ren S., Klawitter S., Greening A., Romer I., et al. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism. Biochim Biophys Acta 2006, 1761:367-376.
92. Bolick D.T., Srinivasan S., Kim K.W., Hatley M.E., Clemens J.J., Whetzel A., et al. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 2005, 25:976-981.
93. Zemann B., Kinzel B., Muller M., Reuschel R., Mechtcheriakova D., Urtz N., et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 2006, 107:1454-1458.
94. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453-21457.
95. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
96. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
97. Massberg S., von Andrian U.H. Fingolimod and sphingosine-1-phosphate - modifiers of lymphocyte migration. N Engl J Med 2006, 355:1088-1091.
98. Kappos L., Radue E.W., O'Connor P., Polman C., Hohlfeld R., Calabresi P., et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010, 362:387-401.
99. Cohen J.A., Barkhof F., Comi G., Hartung H.P., Khatri B.O., Montalban X., et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010, 362:402-415.
100. Sawicka E., Zuany-Amorim C., Manlius C., Brinkmann V., Kemeny D.M., Walker C. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J Immunol 2003, 171:6206-6214.
101. Matsuura M., Imayoshi T., Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int J Immunopharmacol 2000, 22:323-331.
102. Wang F., Tan W., Guo D., He S. Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720. Eur J Pharmacol 2007, 573:230-240.
103. Deguchi Y., Andoh A., Yagi Y., Bamba S., Tsujikawa T., Fujiyama Y. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol Rep 2006, 16:699-703.
104. Daniel C., Sartory N., Zahn N., Geisslinger G., Radeke H.H., Stein J.M. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J Immunol 2007, 178:2458-2468.
105. Song J., Matsuda C., Kai Y., Nishida T., Nakajima K., Mizushima T., et al. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J Pharmacol Exp Ther 2008, 324:276-283.
106. Maki T., Gottschalk R., Ogawa N., Monaco A.P. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation 2005, 79:1051-1055.
107. Keul P., Tolle M., Lucke S., von Wnuck Lipinski K., Heusch G., Schuchardt M., et al. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:607-613.
108. Nofer J.R., Bot M., Brodde M., Taylor P.J., Salm P., Brinkmann V., et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007, 115:501-508.
109. Vadas M., Xia P., McCaughan G., Gamble J. The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction?. Biochim Biophys Acta 2008, 1781:442-447.
110. Snider A.J., Kawamori T., Bradshaw S.G., Orr K.A., Gilkeson G.S., Hannun Y.A., et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J 2009, 23:143-152.
111. Lai W.Q., Irwan A.W., Goh H.H., Howe H.S., Yu D.T., Valle-Onate R., et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 2008, 181:8010-8017.
112. Haberberger R.V., Tabeling C., Runciman S., Gutbier B., Konig P., Andratsch M., et al. Role of sphingosine kinase 1 in allergen-induced pulmonary vascular remodeling and hyperresponsiveness. J Allergy Clin Immunol 2009, 124:933-941. [e931-939].
113. Michaud J., Kohno M., Proia R.L., Hla T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett 2006, 580:4607-4612.
114. Zemann B., Urtz N., Reuschel R., Mechtcheriakova D., Bornancin F., Badegruber R., et al. Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol Lett 2007, 109:56-63.
115. French K.J., Schrecengost R.S., Lee B.D., Zhuang Y., Smith S.N., Eberly J.L., et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003, 63:5962-5969.
116. Maines L.W., French K.J., Wolpert E.B., Antonetti D.A., Smith C.D. Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci 2006, 47:5022-5031.
117. Nishiuma T., Nishimura Y., Okada T., Kuramoto E., Kotani Y., Jahangeer S., et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1085-1093.
118. Maines L.W., Fitzpatrick L.R., Green C.L., Zhuang Y., Smith C.D. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease. Inflammopharmacology 2010, 18:73-85.
119. Puneet P., Yap C.T., Wong L., Lam Y., Koh D.R., Moochhala S., et al. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 2010, 328:1290-1294.
120. Prieschl E.E., Csonga R., Novotny V., Kikuchi G.E., Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 1999, 190:1-8.
121. Hammad S.M., Taha T.A., Nareika A., Johnson K.R., Lopes-Virella M.F., Obeid L.M. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Prostaglandins Other Lipid Mediat 2006, 79:126-140.
122. Kaneider N.C., Lindner J., Feistritzer C., Sturn D.H., Mosheimer B.A., Djanani A.M., et al. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor. FASEB J 2004, 18:1309-1311.
123. Nofer J.R., van der Giet M., Tolle M., Wolinska I., von Wnuck Lipinski K., Baba H.A., et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004, 113:569-581.
124. Li C., Jiang X., Yang L., Liu X., Yue S., Li L. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol 2009, 175:1464-1472.
125. Peng X., Hassoun P.M., Sammani S., McVerry B.J., Burne M.J., Rabb H., et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004, 169:1245-1251.
126. Ogawa R., Takahashi M., Hirose S., Morimoto H., Ise H., Murakami T., et al. A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis. Biochem Biophys Res Commun 2007, 361:621-628.
127. Lai W.Q., Irwan A.W., Goh H.H., Melendez A.J., McInnes I.B., Leung B.P. Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J Immunol 2009, 183:2097-2103.